Mary C. Beckerle - 10 Aug 2026 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Reporting relationship: Director
Issuer ticker: EXEL
Reported as of: 10 Aug 2026
Net transaction value: -$526,512
SEC form: 4
Accepted by SEC: 12 Aug 2026, 19:34:00 UTC
Prior SEC filing: 29 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Nina Ayer, Attorney in Fact

Key filing fact

Mary C. Beckerle filed Form 4 for EXELIXIS, INC. (EXEL) on 12 Aug 2026.

Key facts

This page summarizes Mary C. Beckerle's Form 4 filing for EXELIXIS, INC. (EXEL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Aug 2026, 19:34.

Change

Previous filing in this sequence was filed on 29 May 2026.
Current net transaction value: -$526,512.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001520181 Primary reporting owner

Beckerle Mary C

Relationship: Director
Address: C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA
Signature: /s/ Nina Ayer, Attorney in Fact
Signature date: 12 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXEL transaction

Common Stock

Sale

Transaction value: $526,512
Shares: -9,812
Change %: -38%
Price: $53.66
Shares after: 16,079
Date: 10 Aug 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026.

Footnote F2

Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $53.16 to $54.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

Footnote F3

Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.